Tenbarge Bryce 4
4 · PROGENICS PHARMACEUTICALS INC · Filed Mar 2, 2018
Insider Transaction Report
Form 4
Tenbarge Bryce
Vice President, Commercial
Transactions
- Award
Non-Qualified Stock Option (Right to Buy)
2018-03-01+75,900→ 75,900 totalExercise: $6.62Exp: 2028-03-01→ Common Stock (75,900 underlying)
Footnotes (1)
- [F1]3yr 33% On Vest beginning on 01-Mar-2018